Summary.-114 biopsy specimens from 70 patients with ovarian carcinoma at all stages of disease were submitted for assessment of clonogenic capacity in agar. A highly significant correlation was found between agar clonogenicity and patient survival after biopsy. However, problems related to inherent tumour heterogeneity, quality of sample and tissue disaggregation indicate that this technique may have limited applicability in the routine assessment of patients. Only 41 biopsy specimens (36%) from 31 patients (44.3%o) complied with the prerequisite criteria for agar clonogenic assessment, namely: (a) the confirmed presence of malignant cells in the biopsy, (b) the ability to prepare a single-cell suspension, and (c) adequate viable cell numbers for assay. Furthermore, although the dominant patterns of agar clonogenic growth could be identified and correlated with stage of disease, the heterogeneity in both initial clonogenic capacity and "self-renewal" capacity assessed by the ability of primary clones to propagate in liquid culture and reclone in agar was too inconsistent for the assay to be used as a prognostic index for the individual patient.
LIQUID-CULTURE techniques have been used extensively to characterize and propagate tumour cell lines not only for the study of tumour-cell biology but also in a search for better diagnostic and prognostic tools, and for predictive assays which could be used for the individualization of tumour therapy. However, because of the heterogeneity of tumour material, such studies have met with limited success and have a number of shortcomings. Tumour cells are commonly overgrown by normaltissue cells at early passages, and normal cells can undergo spontaneous transformation with acquisition of malignant characteristics during cell adaptation in primary culture (Mouriquand et al., 1978) . Although defined growth patterns have been found in different tumour classes, they are too inconsistent to permit differential diagnosis (loachim et al., 1974) .
The marker most closely correlated with tumorigenicity is the ability of neoplastic cells to grow in agar as anchorageindependent clones (Barrett & T'so, 1978; Shin et al., 1975) . Exploiting this property, clonal agar assays for human tumour stem cells have been developed (Courtenay & Mills, 1978; and appear to present investigators with a powerful tool for the analysis of the factors influencing the proliferation, maturation and differentiation of tumourcell populations. Attempts have also been made to use these assays predictively for the screening of chemotherapeutic agents (Alberts et al., 1980; Salmon et al., 1978) but the limitations of the agar clonogenic assay, when applied to primary biopsy material, remain ill defined, and the assumption that true human tumour stem cells are being cloned has not been adequately validated.
The correlation between agar clonogenic capacity and tumorigenicity has been derived mainly from experiments with relatively homogeneous, usually undifferentiated cell lines or tumours in highly inbred animal strains, and relatively little is known about the acquisition of this property or its alteration with tumour progression. In applying the assay to primary human tumour biopsy specimens much greater variability might be encountered; in the light of the known heterogeneity of tumours (Mihich et al., 1979 ) the specimen may not be representative of the tumour as a whole, and the extremely slow doubling time of many tumours (Tubiana & Malaise, 1976 ) may enable expression of clonogenic capacity by only that sub-population of stem cells which is capable of the 5-6 doublings required to form a colony within the 21 days of the assay. Such possibilities have significant bearing on the interpretation of assay results.
In an attempt to answer some of these questions ovarian tumour-biopsy specimens were screened for cells clonogenic in agar. This paper describes the correlation of growth in agar culture with basic clinical data and discusses the limitations of the agar-culture assay for the assessment of human tumour stem cells in the light of this study.
MATERIAL AND METHODS
Collection of biop8y material.-Biopsy material was collected from patients with ovarian carcinoma undergoing laparotomy or followup laparoscopy. Representative sections of solid tumour specimens were placed in balanced salt solution (BSS) and effusions were collected into sterile 500ml bottles containing 15,000u of preservative-free heparin. On arrival at the laboratory a portion of the biopsy specimen was placed in neutral formalin for histology and aliquots of ascitic fluid were set aside for cytology in order to confirm the presence of malignant cells.
Preparation and disaggregation of tumour specimens for clonal agar culture.-Solid tumour specimens were finely minced with scissors and suspended in complete medium containing 0.1% collagenase (Sigma, Type 1) and incubated overnight at 37°C in an atmosphere of 7% 02, 10% CO2 and 83% N2.
The suspension was then gently pipetted to break up tissue fragments and centrifuged, and the cell pellet washed twice in BSS to remove residual collagenase. Any remaining aggregates and debris were removed by layering the cell suspension over foetal calf serum (FCS) for 10 min. Aggregates and undigested material sedimented through the serum and the resulting supernatant cell suspension was collected for culture.
Samples of ascitic fluid were centrifuged and the cell pellet was washed twice in BSS and resuspended by gentle pipetting. If ascitic effusions yielded a cell pellet mostly composed of erythrocytes, the cell pellet was resuspended in BSS and layered over Ficoll/ Hypaque (1 079 g/cm3) and centrifuged for 20 min at 2000 g. The cell band at the interface was then collected and the cells were washed as described above. The cell suspension was examined microscopically for aggregates. In some cases aggregation was marked writh few single cells present and most aggregates containing > 100 cells. In these cases the cell suspension was incubated overnight in complete medium containing 0.1% collagenase in an attempt to disperse the cells.
As agar culture is a clonal assay intended to quantify tumour stem cells, great emphasis was placed on the need for a single-cell suspension. Cell counts were made using a haemacytometer, and the proportion of viable cells was determined by their ability to exclude nigrosin. In reality, true single-cell suspensions were difficult to achieve. All samples which contained aggregates > 3-5 cells were excluded from the study.
Culture methods.-The alpha modification of Eagle's medium (Flow) supplemented with 4mM L-glutamine, MEM vitamins, 20 mg/l gentamycin sulphate (Roussel) and 20% FCS (Flow) was used throughout this study.
The osmolarity of all media was routinely monitored (Fiske 08220 VAL freezing-pointdepression osmometer) and maintained at 310 mOsmol. Clonal agar culture was performed in a double-layer agar system using a modification of the method routinely used for the growth of marrow cell colonies in this laboratory and extensively described elsewhere (Bradley et al., 1978 02, 10% CO2 and 83% N2 in sealed plastic boxes. A low, oxygen tension in the gas mixture is used routinely in this laboratory in preference to conventional gas mixtures of CO2 in air, as it has been our experience that cell growth in both agar and liquid cultures is markedly improved under low oxygen tension (Bradley et al., 1978) . Colonies of at least 40 cells were counted and sized with a calibrated eye-piece grid using an Olympus SZ III dissecting binocular microscope with transmitted indirect lighting at x 20 magnification. Where necessary, more detailed inspection of suspected colonies was made using an inverted microscope at x 100 to x 320 magnification.
Establishment and recloning of putative tumour-cell lines.-In order to assess the selfrenewal capacity of putative tumour stem cells, the recloning capacity of our agar colonies was measured. Twenty colonies were plucked randomly from the original agar cultures using fine-tipped micro-pipettes. The pooled colonies were dispersed by gentle pipetting, and seeded in a 25cm2 flask (Costar) in 5 ml of medium. These liquid cultures were incubated at 37°C with weekly refeeding. Cultures exhibiting growth were harvested using 0.01% Pronase (Calbiochem) in phosphate-buffered saline (PBS) containing 0*54 mm EDTA, when there were adequate cell numbers to permit recloning. The cell suspension was centrifuged and the cell pellet was washed twice in BSS before recloning in agar at cell densities ranging from 103 to 2 x 104 cells as described above. The remaining cells were reseeded and passaged in liquid culture with weekly refeeding and split at a 1:4 ratio at confluency.
Rat erythrocyte suspensions -Blood was obtained from rats by cardiac puncture. The plasma and buffy coat were removed after centrifugation and the packed erythrocytes were washed x 5 in isotonic NaCl and centrifuged. Three volumes of BSS were added to one volume of packed erythrocytes and the resulting 1:4 RBC suspension was heated at 44°C for 1 h to destroy residual nucleated cells. Erythrocyte suspensions were stored at 4°C and discarded after 10 days.
RESULTS
The quality and heterogeneity of biopsy specimens was a major obstacle to the routine application of the clonal agar assay to the assessment of the clonogenic capacity of ovarian tumours. In order to make meaningful conclusions about the clonogenic capacity of a tumour population it was decided that certain prerequisites should be met in both sampling and preparation of the tumour material for agar culture. These were: (a) the confirmation of the presence of malignant cells in the biopsy sample by cytological or histological examination; (b) the ability to prepare a single-cell suspension by mechanical or enzymic dispersion; and, (c) the availability of enough viable cells to perform the assay.
Of 114 specimens collected from 70 patients at all stages of disease, only 41 specimens from 31 patients met the above criteria. The grounds for rejection of the 73 specimens not amenable to clonogenic assessment are listed in Table I . A significant number of ascitic effusions contained too few cells for a reliable assay, and low viability with consequent low cellularity was a problem frequently encountered with solid tumour specimens. A number of specimens containing large cellular aggregates which were resistant to mechanical or enzymic dispersion, were also excluded from the study. Twelve specimens had apparently normal histology or cytology, and 3 specimens -were indefinite.
Very rigid criteria were adopted for the assessment of agar clonogenic capacity.
Growth was deemed to have occurred only if clones of healthy, light-refracting cells could be observed at the end of the incubation period. Colonies varied greatly in appearance from tightly packed spherical balls of cells to highly differentiated structures, such as the hollow cystic colonies which were grown from an ascitic effusion taken from a patient with clear-cell carcinoma (Fig. A) . Cell aggregates of < 40 cells (Fig. B) were scored as clusters. Another class of aggregate, composed of a small but indeterminate number of cells with evidence of necrosis and degenerating giant cells (Fig. C) was not scored, as it was felt that they were not true stem-cell clones, but abortive colonies of nonsurviving cells.
Since the agar-culture assay is a functional assay, the assessment of growth was based primarily on the quality of the colonies rather than the absolute plating efficiency, though these properties are closely correlated. Three growth patterns could be defined: In several experiments, a variety of factors, either alone or in various combinations, were included in the culture medium in an attempt to improve the plating efficiency and quality of colony growth. These factors included insulin, transferrin, gonadotrophins, oestradiol, hydrocortisone, pituitary extracts, human milk, epidermal growth factor, fibronectin, glutathione, phorbols, human and mouse spleen-conditioned media and erythrocyte suspensions. With the exception of the erythrocyte suspensions no factor or combination of factors improved the quality of the growth in agar. However, although RBC invariably improved the quality of colonies, and once enabled the detection of clonal growth in two specimens which did not grow without them, the effect on cloning efficiency was variable (Table II) However, there is a highly significant correlation between agar clonogenic capacity and survival of patients after biopsy, when the data is subjected to KaplanMeier survival analysis (Table III) \ |9>yi(Logrank test, x2 = 12-2 on 2 d.f., P < 001). I  NG  NG  NG  I  II  I  NG  II  I  I  NG  NG  I  NG  I  I  NG  NG  NG  NG  NG  I  I  I   NG  NG  NG   I   NG  II  II  NG TABLE IV (Buick et al., 1980; Von Hoff et al., 1980) (Laboisse et al., 1981) and neuroblastomas )genic cell.lines. (Von Hoff et al., 1980) , 1956; Tolmach & Marcus, 1960) and is supported by the observation of related to the Danes (1980) that similar small anchoragetumours (Mihich independent clones comprised in viable )ciated problems cells. Alternatively, these aggregates may preparation for be true clones growing under nutritional obstacle to the deprivation, or deprivation of cell-cell e assay, and not interaction (Buick et al., 1980) . .ssment of agar A tumour stem cell, by definition, would specimens (64%) be expected to have extensive and 0I) in this study measurable self-renewal capacity. Carney countered to a et al. (1980) and Pavelic et al. (1981) were all the specimens unable to show that colonies transferred from semi-solid cultures exhibited con-tinuous replication in liquid culture, though cell suspensions from pools of large colonies were able to induce tumour growth in nude mice (Pavelic et al., 1980) . Our own attempts at propagating clones in agar culture also had limited success (Table IV) . When large clones were plucked from agar, pooled, and resuspended in liquid culture, growth was achieved on 3/6 occasions, and only 2 of these liquid cultures showed clonogenic capacity in agar. Tubiana & Malaise (1976) reviewing the the prognostic and therapeutic implications of tumour-cell kinetics, point out that, although there is no simple proportionality, there is a broad relationship between histological differentiation, growth rate and prognosis. Therefore, Type II growth in agar, which is correlated with poor prognosis (Table III) may be a reflection of shorter doubling times of the tumour population, permitting expression of this property during the assay. Alternatively, agar clonogenic capacity may only be acquired as a late phenotypic marker of tumorigenicity, as suggested by a number of studies (Barrett & T'so, 1978; Hard et al., 1977; Neugut & Weinstein, 1979; Roscoe et al., 1980) . Both explanations are consistent with Nowell's (1976) hypothesis of the clonal evolution of tumour-cell populations, which envisages tumour progression occurring by the sequential selection of increasingly genetically and biologically abnormal sublines with the potential for continued variation. Therefore, agar clonogenic capacity may not be a totally reliable index of the whole spectrum of tumorigenic stem cells at the various stages of disease.
In summary, clonal agar assays for the assessment of individual tumour biopsy specimens have significant limitations. Only 41/114 biopsies were suitable for agar culture, and of these only 23 were able to grow in agar, with only 5 showing Type II growth. The assay therefore appears to be of limited applicability to the individualization of chemotherapeutic regimes. The quality of growth which would enable chemosensitivity to be assessed most precisely (Type II growth) is generally characteristic of patients in very advanced stages of disease, when such an assessment is of least value. Evidence of clonal heterogeneity has not only been found in this study, but has also been demonstrated by MacKintosh et al. (1981) who showed that 5 cell lines derived from individual agar clones grown from a single human ovarian tumour specimen, exhibited differing patterns of growth, morphology and drug sensitivity in culture.
In the light of these reservations and those of other workers (Rupniak & Hill, 1980; Selby & Raghavan, 1981) further basic research aimed at the optimization of this assay system is required. These results also highlight the need for a reliable animal model for the study of tumour progression and of the development of clonal heterogeneity within tumours. 
